PD-L1 on tumour cells may be up-regulated in response to immune attack induced by radiotherapy, which has been demonstrated in preclinical models.7,8 The present study is the first clinical study showing up-regulation of PD-L1 after cCRT (Fig. 1). This evidence concerns the gene CD274 and neoplasm.